These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16177364)

  • 1. Antibodies to the iron uptake ABC transporter lipoproteins PiaA and PiuA promote opsonophagocytosis of Streptococcus pneumoniae.
    Jomaa M; Yuste J; Paton JC; Jones C; Dougan G; Brown JS
    Infect Immun; 2005 Oct; 73(10):6852-9. PubMed ID: 16177364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection.
    Brown JS; Ogunniyi AD; Woodrow MC; Holden DW; Paton JC
    Infect Immun; 2001 Nov; 69(11):6702-6. PubMed ID: 11598041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PiuA and PiaA, iron uptake lipoproteins of Streptococcus pneumoniae, elicit serotype independent antibody responses following human pneumococcal septicaemia.
    Whalan RH; Funnell SG; Bowler LD; Hudson MJ; Robinson A; Dowson CG
    FEMS Immunol Med Microbiol; 2005 Jan; 43(1):73-80. PubMed ID: 15607639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with the iron uptake ABC transporter proteins PiaA and PiuA prevents respiratory infection with Streptococcus pneumoniae.
    Jomaa M; Terry S; Hale C; Jones C; Dougan G; Brown J
    Vaccine; 2006 Jun; 24(24):5133-9. PubMed ID: 16707196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and genetic diversity of the ABC transporter lipoproteins PiuA and PiaA within Streptococcus pneumoniae and related streptococci.
    Whalan RH; Funnell SG; Bowler LD; Hudson MJ; Robinson A; Dowson CG
    J Bacteriol; 2006 Feb; 188(3):1031-8. PubMed ID: 16428407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with LytB protein of Streptococcus pneumoniae activates complement-mediated phagocytosis and induces protection against pneumonia and sepsis.
    Corsini B; Aguinagalde L; Ruiz S; Domenech M; Antequera ML; Fenoll A; García P; García E; Yuste J
    Vaccine; 2016 Dec; 34(50):6148-6157. PubMed ID: 27840016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
    Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to PcpA and PhtD protect mice against Streptococcus pneumoniae by a macrophage- and complement-dependent mechanism.
    Visan L; Rouleau N; Proust E; Peyrot L; Donadieu A; Ochs M
    Hum Vaccin Immunother; 2018 Feb; 14(2):489-494. PubMed ID: 29135332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
    Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with polyamine transport protein PotD protects mice against systemic infection with Streptococcus pneumoniae.
    Shah P; Swiatlo E
    Infect Immun; 2006 Oct; 74(10):5888-92. PubMed ID: 16988268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the targets of cross-reactive antibodies induced by Streptococcus pneumoniae colonization.
    Roche AM; Weiser JN
    Infect Immun; 2010 May; 78(5):2231-9. PubMed ID: 20231407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Immunoprotective Proteins of Streptococcus pneumoniae Identified by Opsonophagocytosis Killing Screen.
    Wang Y; Wen Z; Pan X; Briles DE; He Y; Zhang JR
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29891544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody Response is More Likely to Pneumococcal Proteins Than to Polysaccharide After HIV-associated Invasive Pneumococcal Disease.
    Kantsø B; Green N; Goldblatt D; Benfield T
    J Infect Dis; 2015 Oct; 212(7):1093-9. PubMed ID: 25762789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies Reactive to Commensal
    Shekhar S; Khan R; Ferreira DM; Mitsi E; German E; Rørvik GH; Berild D; Schenck K; Kwon K; Petersen F
    Front Immunol; 2018; 9():747. PubMed ID: 29713324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H; Peng Y; Lin Z; Zhang S; Guo Y
    Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conserved surface accessible nucleoside ABC transporter component SP0845 is essential for pneumococcal virulence and confers protection in vivo.
    Saxena S; Khan N; Dehinwal R; Kumar A; Sehgal D
    PLoS One; 2015; 10(2):e0118154. PubMed ID: 25689507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.
    Arulanandam BP; Lynch JM; Briles DE; Hollingshead S; Metzger DW
    Infect Immun; 2001 Nov; 69(11):6718-24. PubMed ID: 11598043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
    Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of cross-protection against invasive pneumonia caused by heterologous strains following murine Streptococcus pneumoniae nasopharyngeal colonisation despite whole cell ELISAs showing significant cross-reactive IgG.
    Cohen JM; Wilson R; Shah P; Baxendale HE; Brown JS
    Vaccine; 2013 May; 31(19):2328-32. PubMed ID: 23523406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children.
    Henckaerts I; Durant N; De Grave D; Schuerman L; Poolman J
    Vaccine; 2007 Mar; 25(13):2518-27. PubMed ID: 17034907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.